Colorectal Cancer Diagnostics Market could be worth US$ 10,374.68 million by 2028,says Premium Market Insights

Colorectal Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Modality [Imaging Tests (Colonoscopy, CT Colonography, Flexible Sigmoidoscopy, Capsule Endoscopy, and Others), and Stool Based Tests [Faecal Immunochemical Test (FIT), Guaiac-based Faecal Occult Blood Test (gFOBT), and Stool DNA Test)] and End User (Hospitals, Diagnostic Laboratories, Cancer Research Institutes, and Others) The colorectal cancer diagnostics market size is expected to grow from US$ 10,374.68 million in 2022 to US$ 16,996.48 million by 2028; it is estimated to record a CAGR of 8.7% from 2023 to 2028.

Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00031452?utm_source=OpenPR&utm_medium=10823

Competitive Landscape: Colorectal Cancer Diagnostics Market:
Colorectal cancer diagnostics refers to the tools, kits, and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on which the treatment is provided to the patient.March is marked as the National Colorectal Awareness Month in the US. It is dedicated to encouraging patients, survivors, and caregivers to share their stories, advocate for colorectal cancer prevention, and inform others about the importance of early detection. In 2019, the Health Colorectal Cancer Awareness Campaign was launched at the University of California (UCLA) as the first system-wide cancer awareness and prevention effort. The campaign is run as a health leadership commitment to increase awareness about colorectal cancer screening and other related aspects in the UCLA health patient and staff communities, and in medically underserved populations in the greater Los Angeles area. This multifaceted campaign includes public awareness events, Dress in Blue Day, patient and provider education, patient-directed educational videos, community lectures, radio and media appearances, employee wellness and nutrition sessions, and social media promotions. The campaign format was changed slightly in March 2020 due to the COVID-19 pandemic; it provided virtual screening and awareness messages and evolved to include a stronger focus on stool testing to allow patients access to home screening. Owing to such efforts, awareness of colorectal cancer screening is rising in the US, and the screening rates have reached 60% of the country's population which in turn driving the colorectal cancer diagnostics market growth.

Medtronic Plc
Illumina Inc
Clinical Genomics Technologies Pty Ltd
EDP Biotech Corp
Epigenomics AG
Hoffmann-La Roche Ltd
Quest Diagnostics Inc
Novigenix SA
Siemens Healthineers AG
Bruker Corp
Eiken Chemical Co., Ltd.
Bottom of Form

Chapter Details of Protective Cultures Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Protective Cultures Market Landscape
Part 04: Protective Cultures Market Sizing
Part 05: Protective Cultures Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis

Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00031452?utm_source=OpenPR&utm_medium=10823

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sushant More
SE-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

This release was published on openPR.